JPWO2022170280A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022170280A5
JPWO2022170280A5 JP2023547592A JP2023547592A JPWO2022170280A5 JP WO2022170280 A5 JPWO2022170280 A5 JP WO2022170280A5 JP 2023547592 A JP2023547592 A JP 2023547592A JP 2023547592 A JP2023547592 A JP 2023547592A JP WO2022170280 A5 JPWO2022170280 A5 JP WO2022170280A5
Authority
JP
Japan
Prior art keywords
seq
variable region
chain variable
heavy chain
light chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023547592A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024508672A5 (https=
JP2024508672A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/015711 external-priority patent/WO2022170280A2/en
Publication of JP2024508672A publication Critical patent/JP2024508672A/ja
Publication of JP2024508672A5 publication Critical patent/JP2024508672A5/ja
Publication of JPWO2022170280A5 publication Critical patent/JPWO2022170280A5/ja
Pending legal-status Critical Current

Links

JP2023547592A 2021-02-08 2022-02-08 新規抗cd24抗体 Pending JP2024508672A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/076075 2021-02-08
CN2021076075 2021-02-08
CN202210088172.3 2022-01-25
CN202210088172 2022-01-25
PCT/US2022/015711 WO2022170280A2 (en) 2021-02-08 2022-02-08 Novel anti-cd24 antibodies

Publications (3)

Publication Number Publication Date
JP2024508672A JP2024508672A (ja) 2024-02-28
JP2024508672A5 JP2024508672A5 (https=) 2025-02-18
JPWO2022170280A5 true JPWO2022170280A5 (https=) 2025-02-18

Family

ID=82741874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023547592A Pending JP2024508672A (ja) 2021-02-08 2022-02-08 新規抗cd24抗体

Country Status (12)

Country Link
US (1) US20240052052A1 (https=)
EP (1) EP4288099A4 (https=)
JP (1) JP2024508672A (https=)
KR (1) KR20230143177A (https=)
CN (1) CN117412770A (https=)
AU (1) AU2022217072A1 (https=)
CA (1) CA3210934A1 (https=)
CO (1) CO2023011463A2 (https=)
IL (1) IL304898A (https=)
MX (1) MX2023009238A (https=)
TW (1) TW202241956A (https=)
WO (1) WO2022170280A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024251257A1 (en) * 2023-06-09 2024-12-12 TJ Biopharma (Shanghai) Co., Ltd. Anti-cd24 antibodies and uses thereof
GB202316777D0 (en) 2023-11-01 2023-12-13 Cambridge Entpr Ltd New therapeutic use
WO2025101970A1 (en) * 2023-11-08 2025-05-15 Pheast Therapeutics, Inc. Cd24 antibodies
WO2025128830A1 (en) * 2023-12-12 2025-06-19 The Methodist Hospital Therapeutic lilrb regulation for treating neurological disorders
WO2025132836A1 (en) * 2023-12-19 2025-06-26 Pentixapharm Ag Antibodies against cd24
WO2025159754A1 (en) * 2024-01-25 2025-07-31 China Medical University Therapeutic cd24 humanized monoclonal antibodies and anti-tumor translational use
WO2025218729A1 (en) * 2024-04-17 2025-10-23 TJ Biopharma (Shanghai) Co., Ltd. Multifunctional molecules targeting cd24
CN119161485B (zh) * 2024-10-29 2026-03-24 上海中医药大学附属曙光医院 靶向GFRα3的抗体及其制备方法和在抗癌中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080002341A (ko) * 2006-06-30 2008-01-04 재단법인서울대학교산학협력재단 Cd24를 표적으로 하는 암 억제방법
WO2009063461A1 (en) * 2007-11-14 2009-05-22 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Methods of treating cancer using anti cd24 antibodies
ES3012974T3 (en) * 2014-01-08 2025-04-10 Univ Leland Stanford Junior Targeted therapy for lung cancer
AU2015229448B2 (en) * 2014-03-11 2020-09-03 The Board Of Trustees Of The Leland Stanford Junior University Anti SIRP-alpha antibodies and Bi-specific Macrophage Enhancing antibodies
AU2015254257B2 (en) * 2014-04-28 2021-02-25 Medicinal Chemistry Pharmaceuticals, Co., Ltd. Anti-MUC1 antibody or antigen-binding fragment of same, and use thereof
US20170158753A1 (en) * 2014-06-25 2017-06-08 Integrated Biotherapeutics, Inc. Monoclonal antibodies directed against envelope glycoproteins from multiple filovirus species
WO2019222082A1 (en) * 2018-05-14 2019-11-21 Oncoimmune, Inc. Anti-cd24 compositions and uses thereof
KR20210143868A (ko) * 2019-03-26 2021-11-29 포티 세븐, 인코포레이티드 암 치료용 다중특이성 제제
BR112021026133A2 (pt) * 2019-06-25 2022-02-08 Ichilov Tech Ltd Anticorpo anti-cd24 e usos do mesmo

Similar Documents

Publication Publication Date Title
Chen et al. Bispecific antibodies in cancer immunotherapy
JP7600327B2 (ja) Pd-1とvegfを標的とした四価二重特異性抗体、その製造方法および用途
JP2025078629A5 (https=)
IL312224B1 (en) Guidance and navigation control proteins and method of making and using thereof
WO2019005641A1 (en) GUIDING AND NAVIGATION CONTROL PROTEINS AND METHODS OF PRODUCTION AND USE THEREOF
RU2019126655A (ru) Нуклеиновые кислоты, кодирующие химерные рецепторы, полипептидные химерные рецепторы, кодируемые ими, векторы экспрессии, содержащие их, выделенные клетки-хозяева, содержащие их, композиции, содержащие выделенные клетки-хозяева, а также способы получения выделенных клеток-хозяев in vitro, способы выбора нуклеиновых кислот, кодирующих химерные рецепторы, in vitro и способы проведения клеточной иммунотерапии у субъекта, имеющего опухоль
JP2024023228A5 (https=)
JP2020529839A5 (https=)
TWI874613B (zh) 微型導引和導航控制(miniGNC)類抗體蛋白及其製造和使用方法
AU2022217072A9 (en) Novel anti-cd24 antibodies
CN115066274A (zh) 三价结合分子
JP2020522267A (ja) 少なくともcd3及びhsaを標的とするヘテロ二量体多重特異性抗体フォーマット
JPWO2021032157A5 (https=)
JPWO2022170280A5 (https=)
JPWO2023034922A5 (https=)
JPWO2023141611A5 (https=)
TW202321311A (zh) 與scFv等之連接子結合的抗體
JPWO2019219064A5 (https=)
JP7854121B2 (ja) 微小ガイダンス及びナビゲーションコントロール(miniGNC)抗体様タンパク質、その製造方法及び使用方法
JPWO2022016190A5 (https=)
George et al. Bispecific antibody engineering
RU2022107092A (ru) Новые анти-cldn18.2 антитела
CN117794955A (zh) 与scFv等的接头结合的抗体
JPWO2023097024A5 (https=)
NZ807450A (en) Antibodies binding to gprc5d